Basic Information
IPS Genomix was founded in 2013 by a group of experts with over 25 years of experience in the healthcare field in the Middle East and Africa. IPS Genomix collaborates with molecular diagnostics companies in the United States and Europe to provide a diverse range of genomic testing services, focusing on improving patient care through the latest prognostic, predictive, and personalized medical technologies. Treating physicians can personalize treatment for their patients to enhance the prevention and/or treatment of certain conditions and cancers. Given the rapid development in this specific area, IPS Genomix continuously integrates new technological platforms and analyses to provide doctors and their patients with the latest, reliable, and cutting-edge tools for personalized medicine.